Recigar 1.5 mg 100 (Cytisinicline) – 100 Tablets
Prescription-Assisted Smoking Cessation Aid with Textured Dosage Blister Pack
A structured 25-day course containing cytisinicline, a plant-based alkaloid (from golden rain tree) that helps reduce nicotine withdrawal and cravings—financed in several countries for smokers committed to quitting
🌿 What Is It?
Each tablet delivers 1.5 mg cytisinicline, a partial agonist at nicotinic acetylcholine receptors. It binds like nicotine, easing cravings while minimizing stimulation—helping smokers quit gradually
Pack of 100 tablets, arranged in a striped, calendar-labeled blister for daily dosing across a 25-day structured protocol
✅ Key Benefits
-
Gradual reduction of nicotine dependence, with minimal symptoms of withdrawal (anxiety, irritability, insomnia, appetite increase)
-
Supports quit date by day 5, reducing nicotine satisfaction and helping disrupt habitual smoking
-
Backed by funding programs—e.g., in Spain it’s reimbursed for qualifying smokers
🕒 How to Use
Follow this schedule with adequate water:
-
Days 1–3: 1 tablet every 2 h (max 6/day)
-
Days 4–12: 1 every 2.5 h (max 5/day)
-
Days 13–16: 1 every 3 h (max 4/day)
-
Days 17–20: 1 every 5 h (max 3/day)
-
Days 21–25: 1–2 tablets daily (max 2/day)
Quit smoking no later than day 5
⚠️ Precautions & Contraindications
-
Not for use if allergic to cytisinicline or excipients (e.g., aspartame), or with unstable angina, recent MI, arrhythmias, stroke
-
Avoid during pregnancy or breastfeeding, or use in individuals under 18 or over 65
-
Caution in ischemic heart disease, heart failure, hypertension, pheochromocytoma, PUD, GERD, hyperthyroidism, diabetes, psychiatric disorders Smoking concurrently may increase nicotine-related side effects
Monitor for psychiatric symptoms (e.g., mood changes, depression, suicidal thoughts), which may emerge during withdrawal .
📚 Evidence & Clinical Insight
-
Cytisinicline treatment spans 25 days and follows regimens similar to Bulgaria’s Tabex
-
Cochrane meta-analysis and RCTs show significant improvement (~75% increase in quit rates vs placebo); similar effectiveness to varenicline when used with behavioral support
Summary:
Recigar 1.5 mg (Cytisinicline) offers a structured, clinically supported method to quit smoking over a 25-day tapering regimen. Ideal for motivated adult smokers, it moderates withdrawal and supports a quit date by day 5, provided use is monitored for contraindications and side effects.
buy Recigar 1.5 mg 100
order Recigar 1.5 mg 100
